Atea Pharmaceuticals, Inc. SEC filings AVIR
Atea Pharmaceuticals, Inc. has 313 filings in SEC EDGAR's recent list, going back to Dec 11, 2013. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DFAN14A | Filing | Mar 26, 2025 | — |
| EFFECT | Filing | Nov 19, 2024 | — |
| CORRESP | Letter to the SEC | Nov 15, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2024 | — |
| EFFECT | Filing | May 12, 2022 | — |
| POSASR | Filing | Feb 28, 2022 | — |
| EFFECT | Filing | Oct 29, 2020 | — |
| CORRESP | Letter to the SEC | Oct 29, 2020 | — |
| CERT | 8a cert | Oct 28, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 27, 2020 | — |
| CORRESP | Letter to the SEC | Oct 27, 2020 | — |
| CORRESP | Letter to the SEC | Oct 27, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2020 | — |
| 8-A12B | Filing | Oct 26, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 23, 2020 | — |
| DRSLTR | Filing | Aug 7, 2020 | — |
| DRS/A | Filing | Aug 7, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2020 | — |
| DRS | Filing | Jun 19, 2020 | — |
| D | Filing | May 29, 2020 | — |
| D | Filing | Jul 16, 2018 | — |
| D | Filing | Sep 13, 2016 | — |
| D/A | Filing | Sep 17, 2014 | — |
| D/A | Filing | May 21, 2014 | — |
| D | Filing | Dec 11, 2013 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AVIR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1593899
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.